PAR paradigm biopharmaceuticals limited..
Add to My Watchlist 0.86% ! 28.8¢

Ann: Paradigm Secures Ethics Approval for Phase 3 Trial, page-4

  1. Mozzarc
    4,839 Posts.
    lightbulb Created with Sketch. 7525
    clock Created with Sketch.
    24/02/25
    08:15
    Post #: 77989060
    Yes, good required progress, we need ethics to continue.



    Onwards we go!
    PAR Price at posting: 61.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 21  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Ministerial Approval Grants Provisional Authorisation for Battery Anode Material Facility
right-arrow Created with Sketch.
NEWS Pathological Complete Response Recorded in ACCENT Trial of Advanced Pancreatic Cancer
right-arrow Created with Sketch.
NEWS Building Permits Received for Phase One Renewable Power Plant
right-arrow Created with Sketch.
NEWS New Positive Interim Data in Phase 2 Study of SNT-5505 in Myelofibrosis
right-arrow Created with Sketch.
NEWS High-Grade Gold Hits Extend Major Lodes at Kpali Prospect in Ghana
right-arrow Created with Sketch.
NEWS FBR Executes Engineering Service Agreement with Samsung Heavy Industries
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
28.8¢ 		Change
-0.003(0.86%) 		Mkt cap ! $109.0M
Open High Low Value Volume
28.5¢ 29.5¢ 28.0¢ $113.8K 398.7K

Buyers (Bids)

No. Vol. Price($)
21 284682 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 17473 3
View Market Depth
Last trade - 15.28pm 16/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.